Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01138527 · ClinicalTrials.gov registry record
Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach
A clinical trial, sponsored by Radboud University Medical Center.
- Completed
- Registry status
- 148
- Enrollment target
NCT01138527 is a clinical trial that has completed, run by Radboud University Medical Center. The registered enrollment target is 148 participants.
The verdict
NCT01138527 has completed, sponsored by Radboud University Medical Center.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
The primary objective of this prospective multi-centre study is to prove the diagnostic accuracy of in vivo 3T multi-modality Magnetic Resonance Imaging (high resolution T2-weighted MRI, DCE-MRI, MRSI and DWI techniques) in distinguishing carcinoma from other prostate tissue. The gold standard for distinguishing the tissue types is the analysis of whole-mount sections of the resected prostate by a genitourinary histopathologist.
Interventions
- OTHER MRI examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2010-06 |
| Est. Completion | 2019-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01138527
The ClinicalTrials.gov registry entry for NCT01138527 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radboud University Medical Center, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI examination is the first listed.
NCT01138527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01138527 about?
NCT01138527 is a clinical study titled "Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach". The primary objective of this prospective multi-centre study is to prove the diagnostic accuracy of in vivo 3T multi-modality Magnetic Resonance Imaging (high resolution T2-weighted MRI, DCE-MRI, MRSI and DWI techniques) in distinguishing carcinoma from other prostate tissue. The gold standard for d...
What is the current status of trial NCT01138527?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2010-06. Estimated completion is 2019-07.
What interventions are being tested in trial NCT01138527?
The interventions under investigation include: MRI examination (OTHER).
Who is sponsoring clinical trial NCT01138527?
This trial is sponsored by Radboud University Medical Center, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.